Sanofi US
270 Albany Street
Cambridge
Massachusetts
02139
United States
Tel: 800-446-6267
Website: http://www.sanofi.us/
About Sanofi US
Sanofi, a diversified global healthcare leader, discovers, develops, and distributes therapeutic solutions to improve the lives of everyone. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. With more than 100,000 dedicated professionals in more than 100 countries, Sanofi is devoted to advancing healthcare around the world. Sanofi US, with headquarters in Bridgewater, New Jersey, employs more than 17,000 professionals throughout the country. At Sanofi, we work for what really matters: Health.
150 articles with Sanofi US
-
FDA approves Toujeo® Max SoloStar®
3/27/2018
Max SoloStar holds more insulin than any other long-acting insulin pen
-
For the second time Ablynx’s anti-IL-6R Nanobody, vobarilizumab has failed to pass muster. This morning Belgium-based company said vobarilizumab did not meet primary endpoints in a Phase II dosing study for lupus patients.
-
Sanofi and Regeneron have cut deals to dramatically reduce the price of their new cholesterol drug Praluent.
-
Seven months after Prevail Therapeutics launched, the company has secured $75 million in Series A financing to support the development of gene therapies for Parkinson’s disease.
-
Esperion announced that its bempedoic acid for lowering LDL-C cholesterol had positive results in a Phase III clinical trial.
-
While the focus has been on M&A activity, Venture Capital firms have been investing billions in Biotech companies in 2018.
-
Asthma patients may soon have a new treatment option.
-
Sanofi US Collaborates With Duke University And Massachusetts General Hospital On Big Data And Type 2 Diabetes
4/28/2016
-
Sanofi US To Return Auvi-Q (epinephrine injection, USP) Rights To Kaleo
2/24/2016
-
Pozen, Inc. And Sanofi US Mutually Agree To Terminate U.S. Partnership For PA8140/PA32540
12/1/2014
-
Sanofi US Launches Authorized Generic Version Of Eloxatin® (oxaliplatin Injection)
8/12/2014
-
Sanofi-Aventis (Massachusetts) Release: Allegra(R) and Survivor Winner Danni Boatwright Want to Hear About Your "Allergy Adventures"
8/10/2011
-
Gov. Deval Patrick Meets with Sanofi-Aventis (Massachusetts), Genzyme Corporation CEOs to Discuss Job Losses
2/18/2011
-
Albany Molecular Research, Inc. Wtih Sanofi-Aventis (Massachusetts) Files Motion for Preliminary Injunction Prohibiting Dr. Reddy's Laboratories, Inc.'s from Distributing Generic Allegra-D(R) 24
3/23/2010
-
Cegedim Dendrite Announces Extension of Customer Relationship Management (CRM) Agreement with Sanofi-Aventis (Massachusetts)
3/15/2010
-
Sanofi-aventis U.S. Introduces BenzaClin(R) Carekit - Carekit Offers Acne Patients Simple and Convenient Moisturizing Option
8/4/2009
-
Antisoma PLC Sells Oral Fludarabine to Sanofi-Aventis (Massachusetts) for $65 Million
5/12/2009
-
Sanofi-Aventis (New York) And Bristol-Myers Squibb Company Release: Rationale and Design of CURRENT-OASIS 7 Study Published in American Heart Journal
11/6/2008
-
Sanofi-Aventis (France)'s Acomplia Linked To 5 Deaths
6/4/2008
-
Sanofi-Aventis (New York) Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy First Phase III Study
5/27/2008